最後更新 2024-11-21 16:27:31 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

3.4%


截至2024-09-29

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

泰爾菲克斯公司設計、開發、製造和供應用於重症監護和手術應用的單次性醫療器械,用於常見的診斷和治療程序。它提供血管通路產品,包括 Arrow 品牌導管、導管導航和尖端定位系統,以及用於輸注靜脈療法、測量血壓和通過單一穿刺點抽取血液樣本的骨髓內通路系統。該公司還提供介入產品,包括各種冠狀動脈導管、結構性心臟治療以及外周介入和心臟輔助產品,由介入心臟病學家、放射科醫生和血管外科醫生使用;以及 Arrow 品牌導管、Guideline 和 Trapliner 導管、Manta 血管閉合裝置和 Arrow Oncontrol 裝置。它提供麻醉產品,如支持醫院、急救醫學和軍事渠道的呼吸道和疼痛管理產品;以及外科產品,包括金屬和聚合物結紮夾和筋膜閉合外科系統,用於腹腔鏡手術、經皮手術系統和其他外科儀器。該公司還提供介入泌尿產品,包括 UroLift 系統,這是一種治療良性前列腺增生引起的下尿路症狀的創新技術;以及呼吸產品,包括氧療和氣霧療法、肺功能檢查和通氣管理產品,用於各種護理環境。它提供泌尿產品,如導管、尿液收集器和導管配件,以及手術內視鏡泌尿產品;以及膀胱管理服務。該公司為醫院和醫療保健提供商、醫療器械製造商和家庭護理市場提供服務。該公司成立於1943年,總部位於賓夕法尼亞州韋恩。



Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning